Efficacy and safety of caspofungin in solid organ transplant recipients.

[1]  R. Betts,et al.  Caspofungin for the treatment of less common forms of invasive candidiasis. , 2007, The Journal of antimicrobial chemotherapy.

[2]  A. Glasmacher,et al.  Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis , 2006, Cancer.

[3]  Nina Singh,et al.  Treatment of solid organ transplant patients with invasive fungal infections: should a combination of antifungal drugs be used? , 2006, Current opinion in infectious diseases.

[4]  P. Marik.  Fungal infections in solid organ transplantation , 2006, Expert opinion on pharmacotherapy.

[5]  D. Stablein,et al.  Post‐Transplant Infections Now Exceed Acute Rejection as Cause for Hospitalization: A Report of the NAPRTCS 1 , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  J. Sobel,et al.  Guidelines for treatment of candidiasis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  Nina Singh,et al.  Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study1 , 2003, Transplantation.

[8]  J. Perfect,et al.  Comparison of caspofungin and amphotericin B for invasive candidiasis. , 2002, The New England journal of medicine.

[9]  J. Smietana,et al.  A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis. , 2002, The American journal of medicine.

[10]  E. Gotuzzo,et al.  Randomized, Double-Blind, Multicenter Study of Caspofungin versus Amphotericin B for Treatment of Oropharyngeal and Esophageal Candidiases , 2002, Antimicrobial Agents and Chemotherapy.

[11]  E. Gotuzzo,et al.  A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  N. Singh.  Invasive mycoses in organ transplant recipients: controversies in prophylaxis and management. , 2000, The Journal of antimicrobial chemotherapy.

[13]  Nina Singh,et al.  Invasive aspergillosis in transplant recipients. , 1999, Medicine.

[14]  C. Payá,et al.  Fungal infections in solid-organ transplantation. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  J. Ortiz,et al.  Fungal infections in solid organ transplant patients. , 2003, Surgical infections.

[16]  T. Starzl,et al.  Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients. , 1996, Annals of surgery.